Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15485111rdf:typepubmed:Citationlld:pubmed
pubmed-article:15485111lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:15485111lifeskim:mentionsumls-concept:C0021289lld:lifeskim
pubmed-article:15485111lifeskim:mentionsumls-concept:C0035435lld:lifeskim
pubmed-article:15485111lifeskim:mentionsumls-concept:C1274040lld:lifeskim
pubmed-article:15485111pubmed:issue9lld:pubmed
pubmed-article:15485111pubmed:dateCreated2004-10-15lld:pubmed
pubmed-article:15485111pubmed:abstractTextRheumatic autoimmune diseases have a higher prevalence in women, particularly during their childbearing age. Due to improved management, an increasing number of patients plan and carry out one or more pregnancies. Therefore, a growing interest is being paid to the possible consequences of maternal disease and associated treatment on the fetus and newborn infant. If maternal disease is characterized by the presence of IgG isotype autoantibodies, these can cross the placenta with possible antibody-mediated damage to the fetus. This is typically the case of the so called neonatal lupus erythematosus (NLE); a similar mechanism has been shown in infants of patients with immune thrombocytopenic purpura (ITP) and, less frequently, in those from mothers with antiphospholipid syndrome (APS). Indeed, this last condition is often responsible for placental, rather than neonatal, pathology. In addition, immunosuppressive and other drugs administered to the mothers during pregnancy and lactation might affect the fetal and neonatal immune system development. Finally, mothers disease and/or treatment could be related to neuropsychological alteration reported in some of their children.lld:pubmed
pubmed-article:15485111pubmed:languageenglld:pubmed
pubmed-article:15485111pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15485111pubmed:citationSubsetIMlld:pubmed
pubmed-article:15485111pubmed:statusMEDLINElld:pubmed
pubmed-article:15485111pubmed:issn0961-2033lld:pubmed
pubmed-article:15485111pubmed:authorpubmed-author:MottaMMlld:pubmed
pubmed-article:15485111pubmed:authorpubmed-author:MarconiMMlld:pubmed
pubmed-article:15485111pubmed:authorpubmed-author:GorgéAAlld:pubmed
pubmed-article:15485111pubmed:authorpubmed-author:TincaniAAlld:pubmed
pubmed-article:15485111pubmed:authorpubmed-author:ChiricoGGlld:pubmed
pubmed-article:15485111pubmed:authorpubmed-author:FadenDDlld:pubmed
pubmed-article:15485111pubmed:authorpubmed-author:GasparoniAAlld:pubmed
pubmed-article:15485111pubmed:authorpubmed-author:LojaconiGGlld:pubmed
pubmed-article:15485111pubmed:authorpubmed-author:AiròPPlld:pubmed
pubmed-article:15485111pubmed:authorpubmed-author:OwenW BWBlld:pubmed
pubmed-article:15485111pubmed:authorpubmed-author:CiardelliLLlld:pubmed
pubmed-article:15485111pubmed:authorpubmed-author:de...lld:pubmed
pubmed-article:15485111pubmed:issnTypePrintlld:pubmed
pubmed-article:15485111pubmed:volume13lld:pubmed
pubmed-article:15485111pubmed:ownerNLMlld:pubmed
pubmed-article:15485111pubmed:authorsCompleteYlld:pubmed
pubmed-article:15485111pubmed:pagination718-23lld:pubmed
pubmed-article:15485111pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:15485111pubmed:meshHeadingpubmed-meshheading:15485111...lld:pubmed
pubmed-article:15485111pubmed:meshHeadingpubmed-meshheading:15485111...lld:pubmed
pubmed-article:15485111pubmed:meshHeadingpubmed-meshheading:15485111...lld:pubmed
pubmed-article:15485111pubmed:meshHeadingpubmed-meshheading:15485111...lld:pubmed
pubmed-article:15485111pubmed:meshHeadingpubmed-meshheading:15485111...lld:pubmed
pubmed-article:15485111pubmed:meshHeadingpubmed-meshheading:15485111...lld:pubmed
pubmed-article:15485111pubmed:meshHeadingpubmed-meshheading:15485111...lld:pubmed
pubmed-article:15485111pubmed:meshHeadingpubmed-meshheading:15485111...lld:pubmed
pubmed-article:15485111pubmed:meshHeadingpubmed-meshheading:15485111...lld:pubmed
pubmed-article:15485111pubmed:meshHeadingpubmed-meshheading:15485111...lld:pubmed
pubmed-article:15485111pubmed:meshHeadingpubmed-meshheading:15485111...lld:pubmed
pubmed-article:15485111pubmed:meshHeadingpubmed-meshheading:15485111...lld:pubmed
pubmed-article:15485111pubmed:year2004lld:pubmed
pubmed-article:15485111pubmed:articleTitleNeonatal outcome in patients with rheumatic disease.lld:pubmed
pubmed-article:15485111pubmed:affiliationNeonatology and Neonatal Intensive Care, Spedali Civili, Brescia, Italy. lvmott@tin.itlld:pubmed
pubmed-article:15485111pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:15485111pubmed:publicationTypeReviewlld:pubmed